Custom-Designed Kids: How Darwin's Legacy Is Being Abused
By Jesse Reynolds,
AlterNet
| 02. 12. 2009
Charles Darwin -- born 200 years ago today -- remains one of the strongest influences on modern society. His theory of evolution, detailed in On the Origin of Species, sculpts our understanding of what it means to be human more than any other idea outside of religion. We live in Darwin’s shadow, and it casts lingering controversies.
The most obvious of these controversies is over challenges to the role of evolution in educational curricula. That debate flared again just last month in Texas, and has been the topic of high-profile trials from Scopes in 1923 to Dover just three years ago.
Two other contentious conversations about genes and society also continue to haunt America: our legacy of race and racism, and proposals to genetically design our future descendents.
Race and ethnicity have confounded American society from its inception. Before Darwin, racial oppression and inequality were typically justified by invoking a religious “natural order.” After Darwin, “competitive advantage” and “natural selection” provided secular alternatives: In short, whites ruled because they were biologically superior to others.
Around the start of the twentieth...
Related Articles
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...